Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.79 |
| ▸ | TSHR | P16473 | 3/20 | 0.71 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | PDE4A | P27815 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cadaverine Tartrate SCHEMBL10620568 | 0.97 | TP53 (0.73) | TP53TSHRNFKB1CYP2C19SLC7A5 | |
| Tartaric Acid SCHEMBL30100371 | 0.89 | TSHR (0.77) | TP53TSHRNFKB1CYP2C19SLC7A5 | |
| Cadaverine Tartrate SCHEMBL8944188 | 0.89 | TSHR (0.77) | TP53TSHRNFKB1CYP2C19SLC7A5 | |
| D-Lactic Acid SCHEMBL14947 | 0.89 | — | — | |
| Lactic Acid SCHEMBL5189465 | 0.89 | TP53 (1.00) | TP53TSHRSLC7A5LMNA | |
| Lactic Acid SCHEMBL1412661 | 0.89 | TP53 (1.00) | TP53TSHRSLC7A5LMNA | |
| Lactic Acid SCHEMBL9066424 | 0.89 | — | — | |
| D-Lactic Acid SCHEMBL4371722 | 0.89 | TP53 (1.00) | TP53TSHRSLC7A5LMNA | |
| L-Lactic Acid SCHEMBL16958 | 0.89 | — | — | |
| L-Lactic Acid SCHEMBL13165963 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230052708-A1 | NON-REWETTING O/W (OIL IN WATER) EMULSIFICATION SYSTEM FOR HYDROPHOBIC COMPOUNDS | ORGANOCLICK AB (SE) | 2023-02-16 | — | — | US | claimed |
| WO-2021118451-A1 | NON-REWETTING O/W (OIL IN WATER) EMULSIFICATION SYSTEM FOR HYDROPHOBIC COMPOUNDS | ORGANOCLICK AB (SE) | 2021-06-17 | — | — | WO | claimed |
| CN-104127378-A | mPEG-SC20K-HM-3 polypeptide injection as well as preparation method and application thereof | UNIV CHINA PHARMA | 2014-11-05 | — | — | CN | claimed |
| US-20130095043-A1 | SYNTHESIS OF HIGH-PERFORMANCE IRON OXIDE PARTICLE TRACERS FOR MAGNETIC PARTICLE IMAGING (MPI) | KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) | 2013-04-18 | — | — | US | claimed |
| US-8148402-B2 | Isoindolinone derivatives having inhibitory activity against T-type calcium channel and method for preparation thereof | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2012-04-03 | — | — | US | claimed |
| US-20230052708-A1 | NON-REWETTING O/W (OIL IN WATER) EMULSIFICATION SYSTEM FOR HYDROPHOBIC COMPOUNDS | ORGANOCLICK AB (SE) | 2023-02-16 | — | — | US | disclosed |
| EP-4028130-A1 | BENZYL AMINE-CONTAINING 5,6-HETEROAROMATIC COMPOUNDS USEFUL AGAINST MYCOBACTERIAL INFECTION | Shionogi & Co., Ltd (JP) | 2022-07-20 | — | — | EP | disclosed |
| WO-2021118451-A1 | NON-REWETTING O/W (OIL IN WATER) EMULSIFICATION SYSTEM FOR HYDROPHOBIC COMPOUNDS | ORGANOCLICK AB (SE) | 2021-06-17 | — | — | WO | disclosed |
| WO-2021050708-A1 | BENZYL AMINE-CONTAINING 5,6-HETEROAROMATIC COMPOUNDS USEFUL AGAINST MYCOBACTERIAL INFECTION | SHIONOGI & CO., LTD. (JP) | 2021-03-18 | — | — | WO | disclosed |
| EP-2830632-A1 | PARENTERAL FORMULATIONS FOR ADMINISTERING MACROLIDE ANTIBIOTICS | Cempra Pharmaceuticals, Inc. (US) | 2015-02-04 | — | — | EP | disclosed |
| CN-104127378-A | mPEG-SC20K-HM-3 polypeptide injection as well as preparation method and application thereof | UNIV CHINA PHARMA | 2014-11-05 | — | — | CN | disclosed |
| WO-2013148891-A1 | PARENTERAL FORMULATIONS FOR ADMINISTERING MACROLIDE ANTIBIOTICS | CEMPRA PHARMACEUTICALS, INC. (US) | 2013-10-03 | — | — | WO | disclosed |
| EP-1233961-A2 | METHOD FOR PRODUCING 5-(1-PIPERAZINYL)-BENZOFURAN-2-CARBOXAMIDE BY TRANSITION METAL-CATALYZED AMINATION | MERCK PATENT GmbH (DE) | 2002-08-28 | — | — | EP | disclosed |
| EP-1119557-A1 | INDENO-, NAPHTO- AND BENZOCYCLOHEPTA DIHYDROTHIAZOLE DERIVATIVES, THE PRODUCTION THEREOF AND THEIR USE AS ANORECTIC MEDICAMENTS | Aventis Pharma Deutschland GmbH (DE) | 2001-08-01 | — | — | EP | disclosed |
| WO-2001040219-A2 | METHOD FOR PRODUCING 5-(1-PIPERAZINYL)-BENZOFURAN-2-CARBOXAMIDE BY TRANSITION METAL-CATALYZED AMINATION | MERCK PATENT GMBH (DE) | 2001-06-07 | — | — | WO | disclosed |
| US-6051688-A | AMINO ACID SEQUENCE FOR POLYPEPTIDE OF AT LEAST 6 CONTIGUOUS AMINO ACIDS; FOR DIAGNOSIS AND TREATMENT OF NERVOUS SYSTEM DISORDERS; ANTICONVULSANTS; ANTIISCHEMIC/ANTIHYPOXIC AGENTS; ANTIEPILEPTIC AGENTS; ALZHEIMER'S/PARKINSON'S DISEASES | NPS PHARMACEUTICALS, INC. (US) | 2000-04-18 | — | — | US | disclosed |
| WO-2000018749-A1 | INDENO-, NAPHTO- AND BENZOCYCLOHEPTA DIHYDROTHIAZOLE DERIVATIVES, THE PRODUCTION THEREOF AND THEIR USE AS ANORECTIC MEDICAMENTS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2000-04-06 | — | — | WO | disclosed |
| CN-1009828-B | Method for preparing silver-containing catalyst | SHELL INT RESEARCH (NL) | 1990-10-03 | — | — | CN | disclosed |
| US-4914125-A | (S)-emopamil for the treatment of migraine | KNOLL AG (DE) | 1990-04-03 | — | — | US | disclosed |
| CN-86104390-A | The preparation method of silver-containing catalyst | — | 1986-12-24 | — | — | CN | disclosed |